Following in the footsteps of our namesake, Dr. Rosalind Franklin, the faculty and students of the College of Pharmacy are actively involved in research and scholarship, to participate in the pursuit of new knowledge.

Dr. Ateequr Rahman serves as the Director of Research for the College of Pharmacy. He earned his PhD in Pharmacy Administration with a focus on Pharmacoeconomics and Outcomes research from the University of Louisiana at Monroe. Earlier he obtained his MBA with focus in Health Economics from the Northeast Louisiana University. His research areas include Assessment of Electronic and Personal Health Records, Interventions in Rural and Health disparity populations, health-related quality of life, health preference and utility, patient satisfaction and symptom assessment studies. He has co-received over $2.3 millions in Federal and Private grants. He has served as Principal Investigator for the Department of Defense grant and co-investigator on multiple Health Resources and Services Administration (HRSA) studies. He has taught several courses in the schools of pharmacy for the past 20 years. He is a registered Pharmacist and actively involved in the practice of pharmacy.

Dr. Rahman sits on the editorial board, and serves as a reviewer for several journals and meetings in the area of Pharmacoeconomics and Outcomes research. He has presented his research findings in various national and international conferences and published in peer-reviewed Journals.

Dr. John Buolamwini directs the Laboratory for Molecular Design and Drug Discovery. The lab is focused on the following major endeavors:

1. Using chemical tools to dissect disease relevant biological pathways or mechanisms to discover new drug targets.
2. Validation of novel therapeutic targets using pharmacological modulators in both traditional drug discovery and in a systems-oriented approach exploring complex molecular states typified by disease.
3. Using computer-aided drug design and medicinal chemistry to identify and optimize small molecules as modulators and potential therapeutic lead compounds for cardiovascular disease, cancer, Alzheimer’s disease and HIV/AIDS.

In addition, the lab collaborates with other faculty members at 无码群交 and other institutions on various drug discovery-oriented projects, utilizing molecular modeling and synthetic chemistry to develop structure-activity-relationships (SAR) to enable pre-clinical optimization of candidate molecules. Projects include developing RyR2 calcium channel modulators with Dr. Beth Stutzmann at RFUMS; nucleoside transporter and NHE-1 inhibitors with Professor Raúl Gazmuri at RFUMS; mitochondrial nucleoside transporters with Professor Raymond Schinazi at Emory University; MDM2 oncoprotein inhibitors with Professor Ruiwen Zhang at Texas Tech University.

Dr. Eric Walters' research uses computational chemistry to discover and optimize new drug leads, and to understand protein structure and function. Projects include work on HIV protease inhibitors, in collaboration with Professor Arun Ghosh at Purdue University; studies of potassium ion channels with Professor Henry Sackin at RFUMS; studies of citrate transporters with Professor Ronald Kaplan at RFUMS; new oxazolidinone antibiotics with Professor Oludotun Phillips at Kuwait University; mitochondrial transcription factors with Professor Raúl Gazmuri, RFUMS.

Dr. Kristen Ahlschwede has research interests in nanotechnology, nanomedicine, delivery of therapeutic and diagnostic agents to the central nervous system, novel strategies to improve the uptake of nanoparticles at the blood brain barrier and pharmacokinetic data analysis and modeling.

Dr. Jessica Cottreau is an infectious diseases pharmacist, and has research interests in antimicrobial stewardship outcomes in acute and ambulatory care settings. Her academic research areas include factors that influence student progression in pharmacy programs and faculty retention and development.

Dr. Rahul Deshmukh investigates drug metabolism and pharmacokinetics and CYP-mediated drug-drug interactions.

Dr. Sean Kane is a Critical Care pharmacist, with research interests in septic shock, pharmacokinetics in critically ill patients, and using podcasting as an educational modality.

Dr. Abbie Lyden is involved in clinical research in Emergency Medicine, particularly in evaluating the impact of clinical pharmacists on the reduction of medication errors, toxicology, and critical care.

Dr. Ateequr Rahman earned his PhD in Pharmacy Administration, with a focus on pharmacoeconomics and outcomes. His research areas include assessment of electronic and personal health records, interventions in rural and health disparity populations, health-related quality of life, health preference and utility, patient satisfaction and symptom assessment studies.